Predictive value of pretreatment metabolic activity measured by fluorodeoxyglucose positron emission tomography in patients with metastatic advanced gastric cancer: the maximal SUV of the stomach is a prognostic factor - Park, J C (Eur J Nucl Med Mol Imaging, 2012)
et al.